|
Previous test result
|
Age group, years
|
Pr to test positive in % (99%-CI)
|
|---|
|
Women
|
Men
|
|---|
|
Screening under 25 years
|
Screening in pregnancy
|
Diagnostic testing
|
All tests
|
|---|
|
Negative
|
15–19
|
4.3 (4.1–4.6)
|
6.5 (6.0–8.1)
|
5.3 (4.8–5.8)
|
9.2 (5.9–14.1)
|
|
20–24
|
3.4 (3.2–3.5)
|
3.0 (2.9–3.4)
|
4.6 (4.3–4.9)
|
10.7 (9.0–12.6)
|
|
25–29
|
–
|
1.1 (1.0–1.3)
|
3.1 (2.9–3.4)
|
9.5 (8.0–11.2)
|
|
30–34
|
–
|
0.4 (0.4–0.5)
|
1.6 (1.4–1.9)
|
7.8 (6.5–9.3)
|
|
35–39
|
–
|
0.3 (0.2–0.4)
|
1.2 (1.0–1.5)
|
6.4 (5.2–7.9)
|
|
40+
|
–
|
0.3 (0.1–0.6)
|
1.1 (0.9–1.3)
|
5.5 (4.8–6.3)
|
|
Positive
|
15–19
|
12.6 (11.3–14.0)
|
28.4 (34.3–45.7)
|
16.8 (15.7–18.1)
|
18.6 (12.7–26.4)
|
|
20–24
|
9.8 (9.1–10.4)
|
18.5 (20.6–24.9)
|
12.7 (12.0–13.4)
|
19.2 (16.7–22.0)
|
|
25–29
|
–
|
10.4 (10.0–13.3
|
10.1 (9.2–11.0)
|
16.6 (14.3–19.3)
|
|
30–34
|
–
|
7.9 (6.8–10.8)
|
7.1 (6.0–8.4)
|
16.4 (13.8–19.5)
|
|
35–39
|
–
|
6.4 (4.3–10.7)
|
8.8 (6.9–11.0)
|
15.4 (12.3–19.1)
|
|
40+
|
–
|
5.9 (2.3–17.2)
|
5.9 (4.3–8.1)
|
16.9 (14.7–19.4)
|
|
Unknown
|
15–19
|
4.9 (4.7–5.0)
|
9.7 (10.2–11.3)
|
8.1 (7.7–8.4)
|
16.9 (15.7–18.2)
|
|
20–24
|
5.7 (5.6–5.8)
|
5.8 (6.0–6.4)
|
8.3 (8.0–8.6)
|
22.3 (21.6–23.1)
|
|
25–29
|
–
|
2.2 (2.1–2.3)
|
5.1 (5.0–5.3)
|
18.0 (17.3–18.7)
|
|
30–34
|
–
|
1.1 (1.0–1.1)
|
2.9 (2.7–3.0)
|
12.4 (11.8–13.1)
|
|
35–39
|
–
|
0.7 (0.6–0.8)
|
1.9 (1.8–2.1)
|
9.4 (8.8–10.1)
|
|
40+
|
–
|
0.6 (0.5–0.8)
|
1.6 (1.5–1.7)
|
6.1 (5.8–6.4)
|
